Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating ...
Dec 09, 2014
not rated yet | 1
Together with a team at the Erasmus Medical Center in Rotterdam, LMU researchers have developed a candidate vaccine directed against the avian flu virus H5N1 and have now carried out the first tests in humans.
Nov 25, 2014
not rated yet | 0